Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by U.S. Patient Advocacy Groups

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among U.S. patient groups who reported working with, or who were familiar with the company.

Related Keywords

Atlanta ,Georgia ,United States ,Minnesota ,Wisconsin ,Ireland ,Matt Flesch ,Eimear Rigby ,Catherine Riedel ,Rareis Scholarship Fund ,National Presenting Sponsor For Arthritis Foundation ,Facebook ,Hmong Institute ,Rareis Adoption Fund ,Twitter ,Nasdaq ,Everylife Foundation For Rare Diseases ,Corporate Communications ,Linkedin ,National Kidney Foundation Of Minnesota ,Instagram ,Horizon Therapeutics ,Rare Autoimmune Emerging Leader Summit ,Thyroid Eye Disease ,Mobile Exhibit ,National Presenting Sponsor ,Arthritis Foundation ,Cure Arthritis ,National Kidney Foundation ,Global Advocate Grant ,Scholarship Fund ,Everylife Foundation ,Rare Diseases ,Adoption Fund ,Corporate Visibility ,Media Strategy ,Media Contact ,Gefallene Big Techs ,Horizon ,Herapeutics ,Banks ,First ,Verall ,Corporate ,Reputation ,Patient ,Advocacy ,Groups ,